Akci\u011fer kanseri hem \u00fclkemizde hem de d\u00fcnyada en s\u0131k g\u00f6r\u00fclen ve en fazla ya\u015fam kayb\u0131na neden olan kanser t\u00fcr\u00fc olarak \u00f6nemini koruyor. Artan \u00e7evresel risk fakt\u00f6rleri, sigara kullan\u0131m\u0131 ve ge\u00e7 belirti vermesi nedeniyle hastal\u0131k toplum sa\u011fl\u0131\u011f\u0131 a\u00e7\u0131s\u0131ndan kritik bir konumda bulunuyor. 2025 y\u0131l\u0131nda tan\u0131 ve tedavide ya\u015fanan geli\u015fmeler ise pek \u00e7ok hasta i\u00e7in yeni bir umut d\u00f6neminin ba\u015flang\u0131c\u0131n\u0131 i\u015faret ediyor. Memorial G\u00f6ztepe Hastanesi Kanser Merkezi Ba\u015fkan\u0131 Prof. Dr. Mustafa \u00d6zdo\u011fan, \u201c17 Kas\u0131m D\u00fcnya Akci\u011fer Kanseri G\u00fcn\u00fc\u201d kapsam\u0131nda hastal\u0131kla ilgili g\u00fcncel verileri ve yeni tedavi yakla\u015f\u0131mlar\u0131n\u0131 payla\u015ft\u0131.<\/p>\n
Her y\u0131l 2.5 milyon ki\u015fi akci\u011fer kanserine yakalan\u0131yor\u00a0<\/p>\n
Akci\u011fer kanseri, d\u00fcnya genelinde hala en s\u0131k g\u00f6r\u00fclen ve en \u00e7ok can kayb\u0131na neden olan kanser t\u00fcr\u00fcd\u00fcr. 2022 y\u0131l\u0131 verilerine g\u00f6re her y\u0131l d\u00fcnyada yakla\u015f\u0131k 2.5 milyon ki\u015fi bu hastal\u0131\u011fa yakalanmakta ve bu, t\u00fcm kanser vakalar\u0131n\u0131n y\u00fczde 12\u2019sine denk gelmektedir. Ayn\u0131 y\u0131l i\u00e7inde ise 1.8 milyon ki\u015fi akci\u011fer kanseri nedeniyle hayat\u0131n\u0131 kaybetmi\u015ftir. Bu da kansere ba\u011fl\u0131 ya\u015fam kay\u0131plar\u0131n\u0131n neredeyse be\u015fte birinin tek ba\u015f\u0131na bu hastal\u0131ktan kaynakland\u0131\u011f\u0131n\u0131 ortaya koymaktad\u0131r.<\/p>\n
\u00dclkemizde her y\u0131l 41 bin yeni vaka<\/p>\n
\u00dclkemizde de tablo d\u00fcnya ile paralellik g\u00f6stermektedir. 2022 verilerine g\u00f6re \u00fclkemizde her y\u0131l yakla\u015f\u0131k 41 bin yeni akci\u011fer kanseri vakas\u0131 tespit edildi ve akci\u011fer kanseri T\u00fcrkiye\u2019de en s\u0131k g\u00f6r\u00fclen kanser konumunda. Ayn\u0131 y\u0131l 38 bin 500 ki\u015fi bu hastal\u0131k nedeniyle ya\u015fam\u0131n\u0131 yitirdi. Yani \u00fclkemizde kansere ba\u011fl\u0131 her \u00fc\u00e7 \u00f6l\u00fcmden biri akci\u011fer kanserinden kaynaklanmaktad\u0131r.<\/p>\n
\u00c7evresel fakt\u00f6rler genetikten \u00e7ok daha bask\u0131n<\/p>\n
Genetik yatk\u0131nl\u0131k baz\u0131 ki\u015filerde \u00f6nemli rol oynasa da toplam risk durumuna bak\u0131ld\u0131\u011f\u0131nda \u00e7evresel fakt\u00f6rler \u00e7ok daha bask\u0131n durumdad\u0131r. Akci\u011fer kanserinin art\u0131k \u00e7o\u011funlukla \u00e7evresel nedenlerle ortaya \u00e7\u0131kt\u0131\u011f\u0131 s\u00f6ylenebilir.<\/p>\n
\tSigara: Vakalar\u0131n yakla\u015f\u0131k y\u00fczde 70\u2019i sigaraya ba\u011fl\u0131
\n\tHava kirlili\u011fi: PM2.5 her 10 \u00b5g artt\u0131\u011f\u0131nda \u00f6l\u00fcm riski y\u00fczde 8 art\u0131yor
\n\tRadon gaz\u0131: Sigara i\u00e7meyenlerde en \u00f6nemli risk fakt\u00f6r\u00fc
\n\tMesleki maruziyetler: Asbest, silika, dizel egzozu, kaynak duman\u0131
\n\tPasif i\u00e7icilik\u00a0
\n\tGe\u00e7mi\u015fte akci\u011fer hastal\u0131\u011f\u0131 \u00f6yk\u00fcs\u00fc olmas\u0131<\/p>\n
Kad\u0131nlarda neden akci\u011fer kanseri art\u0131yor?<\/p>\n
Erkeklerde yeni vaka say\u0131s\u0131 son y\u0131llarda azalma e\u011filimindeyken, kad\u0131nlarda dikkat \u00e7ekici bir art\u0131\u015f s\u00f6z konusu. Kad\u0131nlarda \u00f6zellikle \u201cadenokarsinom\u201d ad\u0131 verilen alt tip daha s\u0131k g\u00f6r\u00fclmekte ve bu tip, hi\u00e7 sigara i\u00e7memi\u015f ki\u015filerde g\u00f6r\u00fclen akci\u011fer kanserlerinin b\u00fcy\u00fck k\u0131sm\u0131n\u0131 olu\u015fturmaktad\u0131r.\u00a0<\/p>\n
Akci\u011fer kanseri erkeklerde daha s\u0131k g\u00f6r\u00fclse de kad\u0131nlardaki art\u0131\u015f\u0131n da \u00f6nemsenmesi gerekmektedir. Artan sigara kullan\u0131m\u0131, ev i\u00e7i duman ve yemek buhar\u0131, odun veya k\u00f6m\u00fcr sobas\u0131 duman\u0131, pasif i\u00e7icilik, hormonlar\u0131n h\u00fccresel d\u00f6n\u00fc\u015f\u00fcme etkisi, genetik yatk\u0131nl\u0131klar\u0131n \u00e7evresel fakt\u00f6rlerle birle\u015fmesi bunun en \u00f6nemli nedenleri aras\u0131ndad\u0131r. K\u0131sacas\u0131 kad\u0131nlar hi\u00e7 sigara i\u00e7meseler bile akci\u011fer kanserine yakalanma riskleri erkeklere g\u00f6re bir miktar daha y\u00fcksek olmaktad\u0131r.<\/p>\n
E-sigara zarars\u0131z de\u011fil!<\/p>\n
Elektronik sigaralar\u0131n ise san\u0131ld\u0131\u011f\u0131 kadar masum olmad\u0131\u011f\u0131n\u0131n bilinmesi gerekmektedir. 2025\u2019te yap\u0131lan geni\u015f analizlerde e-sigara kullanan ki\u015filerde kanserle ili\u015fkili biyobelirte\u00e7lerin y\u00fckseldi\u011fi tespit edilmi\u015ftir. Nikotin ba\u011f\u0131ml\u0131l\u0131k yapmakta ve gen\u00e7lerde geleneksel sigaraya ba\u015flama oran\u0131n\u0131 3 kat art\u0131rmaktad\u0131r. Akci\u011fer kanserinin yakla\u015f\u0131k y\u00fczde 70\u2019i sigaradan kaynaklanmaktad\u0131r. Sigaray\u0131 tamamen hayat\u0131m\u0131zdan \u00e7\u0131kard\u0131\u011f\u0131m\u0131zda, akci\u011fer kanseri neredeyse yok olacak denilebilir.<\/p>\n
Akci\u011fer kanserinde erken tan\u0131 i\u00e7in bu belirtileri \u00f6nemseyin!<\/p>\n
\u00d6zellikle 40 ya\u015f \u00fczeri ve sigara i\u00e7en ki\u015filerde d\u00fczenli kontroller \u00f6nemlidir. 50 ya\u015f \u00fczeri ve sigara i\u00e7mi\u015f ki\u015filerde y\u0131ll\u0131k d\u00fc\u015f\u00fck doz akci\u011fer tomografisi taramas\u0131 erken te\u015fhis sa\u011flar. Akci\u011fer kanseri \u00e7o\u011fu zaman uzun s\u00fcre belirti vermeden ilerleyebilir. Yine de bu uyar\u0131 i\u015faretleri ciddiye al\u0131nmal\u0131d\u0131r:<\/p>\n
\tGe\u00e7meyen \u00f6ks\u00fcr\u00fck
\n\tKanl\u0131 balgam
\n\tNefes darl\u0131\u011f\u0131
\n\tG\u00f6\u011f\u00fcs a\u011fr\u0131s\u0131
\n\t\u0130\u015ftahs\u0131zl\u0131k, kilo kayb\u0131
\n\tSes k\u0131s\u0131kl\u0131\u011f\u0131
\n\tTekrarlayan zat\u00fcrre<\/p>\n
Akci\u011fer kanserinde tedavi yakla\u015f\u0131mlar\u0131n\u0131 de\u011fi\u015ftiren y\u0131l 2025<\/p>\n
2025, akci\u011fer kanseri tedavisinde \u00f6nemli geli\u015fmelerin ya\u015fand\u0131\u011f\u0131 bir y\u0131l oldu. Hedefe y\u00f6nelik tedavilerde taletrectinib, ROS1 pozitif ve beyne yay\u0131lm\u0131\u015f hastalarda etkili sonu\u00e7lar verirken; datopotamab deruxtecan EGFR mutasyonlu hastalarda t\u00fcm\u00f6r h\u00fccrelerini do\u011frudan hedef alan yap\u0131s\u0131yla daha az yan etkiyle y\u00fcksek ba\u015far\u0131 sa\u011flad\u0131. \u0130mm\u00fcnoterapi, art\u0131k yaln\u0131zca ileri evre hastalarda de\u011fil, ameliyat \u00f6ncesi ve sonras\u0131 d\u00f6nemde de kullan\u0131lmaya ba\u015flanarak tedavi s\u00fcrecinde yeni bir standart haline geldi.\u00a0<\/p>\n
Cerrahi alanda kapal\u0131 y\u00f6ntem VATS tekni\u011finin yayg\u0131nla\u015fmas\u0131, hastalara daha h\u0131zl\u0131 iyile\u015fme ve daha az a\u011fr\u0131 avantaj\u0131 sundu. Tan\u0131da \u00f6nem kazanan s\u0131v\u0131 biyopsi testleri, kanda dola\u015fan t\u00fcm\u00f6r DNA\u2019s\u0131n\u0131 tespit ederek hastal\u0131\u011f\u0131n tekrarlamas\u0131n\u0131 \u00e7ok daha erken belirleme imk\u00e2n\u0131 sa\u011flad\u0131. Y\u0131llard\u0131r s\u0131n\u0131rl\u0131 se\u00e7eneklerin bulundu\u011fu k\u00fc\u00e7\u00fck h\u00fccreli akci\u011fer kanserinde ise tarlatamab isimli ila\u00e7, daha \u00f6nce tedavi se\u00e7ene\u011fi kalmam\u0131\u015f hastalarda bile t\u00fcm\u00f6r\u00fc k\u00fc\u00e7\u00fclterek dikkat \u00e7ekici bir ilerleme sundu.<\/p>\n
\u00a0<\/p>\n
Kaynak: (BYZHA) Beyaz Haber Ajans\u0131<\/p>\n","protected":false},"excerpt":{"rendered":"
Akci\u011fer kanseri hem \u00fclkemizde hem de d\u00fcnyada en s\u0131k g\u00f6r\u00fclen ve en fazla ya\u015fam kayb\u0131na neden olan kanser t\u00fcr\u00fc olarak \u00f6nemini koruyor.<\/p>\n","protected":false},"author":1,"featured_media":6179,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[2477,769,358,2478,3235],"class_list":["post-6178","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-saglik","tag-akciger","tag-kanser","tag-kanseri","tag-sigara","tag-ulkemizde"],"_links":{"self":[{"href":"https:\/\/vansondakikahaberler.com.tr\/index.php\/wp-json\/wp\/v2\/posts\/6178","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vansondakikahaberler.com.tr\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/vansondakikahaberler.com.tr\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/vansondakikahaberler.com.tr\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/vansondakikahaberler.com.tr\/index.php\/wp-json\/wp\/v2\/comments?post=6178"}],"version-history":[{"count":0,"href":"https:\/\/vansondakikahaberler.com.tr\/index.php\/wp-json\/wp\/v2\/posts\/6178\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vansondakikahaberler.com.tr\/index.php\/wp-json\/wp\/v2\/media\/6179"}],"wp:attachment":[{"href":"https:\/\/vansondakikahaberler.com.tr\/index.php\/wp-json\/wp\/v2\/media?parent=6178"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/vansondakikahaberler.com.tr\/index.php\/wp-json\/wp\/v2\/categories?post=6178"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/vansondakikahaberler.com.tr\/index.php\/wp-json\/wp\/v2\/tags?post=6178"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}